Table 1.
Baseline characteristics in study 1.
| IM |
||||||
|---|---|---|---|---|---|---|
| 0.059/1 | 0.29/5 | 1.5/25 | 2.9/50 | 5.9/100 | Placebo | |
| n | 8 | 9 | 8 | 7 | 9 | 8 |
| Age (years) | 32.1 (6.7) | 29.8 (7.0) | 26.8 (5.7) | 33.4 (8.1) | 26.9 (4.2) | 33.1 (8.2) |
| Weight (kg) | 68.20 (13.95) | 69.00 (8.40) | 68.55 (10.87) | 58.93 (6.94) | 63.77 (10.51) | 71.89 (10.41) |
| Height (cm) | 173.3 (10.5) | 172.8 (6.9) | 170.3 (9.5) | 164.1 (6.1) | 173.6 (8.2) | 167.4 (6.5) |
| Sex | ||||||
| Female | 4 (50%) | 4 (44%) | 5 (63%) | 4 (57%) | 4 (44%) | 7 (88%) |
| Race | ||||||
| Asian | 1 (13%) | 1 (11%) | 1 (13%) | 1 (14%) | 0 | 0 |
| Black or African American | 0 | 2 (22%) | 1 (13%) | 2 (29%) | 0 | 1 (13%) |
| White | 7 (88%) | 6 (67%) | 6 (75%) | 4 (57%) | 9 (100%) | 7 (88%) |
Data are mean (SD) or n (%), unless otherwise indicated. Vaccine groups are quantified as per μg of OAg/μg of protein. IM = intramuscular.